Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1990-1-2
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0003-987X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
125
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1692-7
|
pubmed:dateRevised |
2008-3-17
|
pubmed:meshHeading | |
pubmed:year |
1989
|
pubmed:articleTitle |
Will 1,25-dihydroxyvitamin D3, MC 903, and their analogues herald a new pharmacologic era for the treatment of psoriasis?
|
pubmed:affiliation |
Vitamin D, Skin, and Bone Research Laboratory Boston University School of Medicine MA 02118.
|
pubmed:publicationType |
Journal Article,
Comment,
Review
|